Bacha, J.; Mayalla, B.; Chodota, M. et all....
(Journal of the International AIDS Society, 2021)
Current guidelines recommend using dolutegravir (DTG) as a preferred ART regimen in eligible CALHIV. However, descriptions of CALHIV who remain virologically unsuppressed despite treatment with DTG remain unknown. We aimed ...